Found: 42
Select item for more details and to access through your institution.
Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1474869
- By:
- Publication type:
- Article
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00855-9
- By:
- Publication type:
- Article
High‐purity isolation platelets by gradient centrifugation plus filtration.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 2, p. 187, doi. 10.1111/ijlh.13998
- By:
- Publication type:
- Article
Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large BCell Lymphoma.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.066
- By:
- Publication type:
- Article
Interim PET/CT result is the sole prognostic factor of survival in patients with advanced-stage diffuse large B-cell lymphoma: a subset analysis of a prospective trial.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2021, v. 327, n. 1, p. 353, doi. 10.1007/s10967-020-07511-z
- By:
- Publication type:
- Article
Liposomal irinotecan (HR070803) in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors: a phase 1b dose-escalation and expansion study.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 4, p. 462, doi. 10.1007/s10637-024-01442-2
- By:
- Publication type:
- Article
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1742, doi. 10.1002/ajh.27064
- By:
- Publication type:
- Article
Hepatitis B Virus Pregenomic RNA Reflecting Viral Replication in Distal Non-tumor Tissues as a Determinant of the Stemness and Recurrence of Hepatocellular Carcinoma.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.830741
- By:
- Publication type:
- Article
Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 11, p. 1721, doi. 10.1007/s00277-012-1507-1
- By:
- Publication type:
- Article
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 837, doi. 10.1007/s00277-011-1375-0
- By:
- Publication type:
- Article
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003).
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2991, doi. 10.1007/s00262-023-03467-7
- By:
- Publication type:
- Article
Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1897, doi. 10.1007/s00262-021-03102-3
- By:
- Publication type:
- Article
Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma.
- Published in:
- Journal of Oncology, 2021, p. 1, doi. 10.1155/2021/3869438
- By:
- Publication type:
- Article
Prognostic significance of clinical characteristics and 18 Fluorodeoxyglucose-positron emission tomography/computed tomography quantitative parameters in patients with primary mediastinal B-cell lymphoma.
- Published in:
- Journal of International Medical Research, 2022, v. 50, n. 1, p. 1, doi. 10.1177/03000605211063027
- By:
- Publication type:
- Article
Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 16, p. 1, doi. 10.1002/cam4.70142
- By:
- Publication type:
- Article
Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T‐cell lymphoma patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 15, p. 5400, doi. 10.1002/cam4.3207
- By:
- Publication type:
- Article
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.747950
- By:
- Publication type:
- Article
Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow‐up of the multicenter, single‐arm, Phase 2 study.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 984, doi. 10.1002/ijc.33852
- By:
- Publication type:
- Article
PDGFD induces ibrutinib resistance of diffuse large B-cell lymphoma through activation of EGFR.
- Published in:
- Molecular Medicine Reports, 2020, v. 21, n. 5, p. 2209, doi. 10.3892/mmr.2020.11022
- By:
- Publication type:
- Article
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 3, p. 243, doi. 10.1111/j.1600-0609.2010.01474.x
- By:
- Publication type:
- Article
Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors.
- Published in:
- BMC Surgery, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12893-023-02291-1
- By:
- Publication type:
- Article
Pretreatment <sup>18</sup>F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02076-x
- By:
- Publication type:
- Article
A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 547, doi. 10.1007/s00280-014-2656-9
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of polymeric micelleformulated paclitaxel in adult Chinese patients with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Phase I and pharmacokinetic study of polymeric micelle-formulated paclitaxel in adult Chinese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 6, p. 1173, doi. 10.1007/s00280-014-2452-6
- By:
- Publication type:
- Article
China Anti-Cancer Association (CACA) guidelines for holistic integrative management of lymphoma (version 2022).
- Published in:
- Holistic Integrative Oncology, 2023, v. 2, n. 1, p. 1, doi. 10.1007/s44178-023-00063-8
- By:
- Publication type:
- Article
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 372, doi. 10.1007/s12185-022-03358-0
- By:
- Publication type:
- Article
Safety of ambulatory laparoscopic cholecystectomy in the elderly.
- Published in:
- ANZ Journal of Surgery, 2021, v. 91, n. 4, p. 597, doi. 10.1111/ans.16656
- By:
- Publication type:
- Article
Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 5041, doi. 10.2147/CMAR.S260974
- By:
- Publication type:
- Article
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-016-0384-9
- By:
- Publication type:
- Article
A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-8722-7-22
- By:
- Publication type:
- Article
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-86
- By:
- Publication type:
- Article
Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 4, p. 504, doi. 10.1002/jcph.1042
- By:
- Publication type:
- Article
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1259, doi. 10.1093/oncolo/oyad163
- By:
- Publication type:
- Article
Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 638, doi. 10.1634/theoncologist.2017-0137
- By:
- Publication type:
- Article
Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1474869
- By:
- Publication type:
- Article
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 145, doi. 10.2147/OTT.S117007
- By:
- Publication type:
- Article
Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Lesion at Presentation: Case Report and Literature Review.
- Published in:
- Acta Haematologica, 2012, v. 127, n. 2, p. 124, doi. 10.1159/000334703
- By:
- Publication type:
- Article
HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China.
- Published in:
- Medical Oncology, 2014, v. 31, n. 3, p. 1, doi. 10.1007/s12032-014-0845-3
- By:
- Publication type:
- Article